7.2 Tumour specific antioxidant nanoparticles to reduce the effect on normal cells Lipid peroxidation can be quenched selectively within the tumour microenvironment (TME) by using tumour -targeted antioxidant nanoparticles as a complex strategy
Orforglipron represents a potential new therapeutic option for individuals with type 2 diabetes considering initiation of GLP-1 receptor agonist therapy who might prefer an alternative to the subcutaneous route of administration, Julio Rosenstock, MD, FACE, senior scientific advisor for Velocity Clinical Research, director of Velocitys site at Medical City Dallas and clinical professor of medicine at the University of Texas Southwestern Medical Center, and colleagues wrote
What is Wegovy, the controversial new Hollywood weight loss drug
However, no significant differences were detected in other outcomes, including nonmotor symptoms, cognition, finger tapping, walking speed, and levodopa equivalent dose [97]